Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB vs SCOPOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SARILUMAB vs SCOPOLAMINE: Safety Overview

Metric SARILUMAB SCOPOLAMINE
Total FAERS Reports 21,493 2,747
Deaths Reported 1,983 219
Death Rate 9.2% 8.0%
Hospitalizations 3,538 497
Average Patient Age 57.5 yrs 49.3 yrs
% Female Patients 84.4% 70.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Sanofi-Aventis U.S. LLC Bryant Ranch Prepack
Route SUBCUTANEOUS TRANSDERMAL
Marketing Status Prescription Prescription